|
Volumn 33, Issue 13, 2006, Pages 1985-1990
|
Adjuvant chemotherapy for non-small cell lung cancer
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DRUG DERIVATIVE;
NAVELBINE;
TEGAFUR;
UFT(R) DRUG;
UNCLASSIFIED DRUG;
URACIL;
VINBLASTINE;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
LUNG TUMOR;
META ANALYSIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL RATE;
ADENOCARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG COMBINATIONS;
HUMANS;
LUNG NEOPLASMS;
META-ANALYSIS;
PNEUMONECTOMY;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL RATE;
TEGAFUR;
URACIL;
VINBLASTINE;
|
EID: 33846921594
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (12)
|